Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.
Research Interests

Papers共 270 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
ADAM12 Promotes Temozolomide Resistance in Glioblastoma by Activating the TNF-α - NF-κB Pathway
Chunchao Cheng, Longtao Cui,Xiaoteng Cui,Qi Zhan, Jiasheng Ju,Biao Hong, Yanping Huang, Yaqing Ding, Hanyi Xu, Tian Qiu,Chunsheng Kang, Xiaomin Liu,Qixue Wang,Liang Zeng
Cancer letters (2025): 217684-217684
Cited0Views0WOSBibtex
0
0
Intrathecal Nivolumab and IL-2 for Treatment of Leptomeningeal Metastases in EGFR-mutated Lung Adenocarcinoma
Zhaohui Ruan,Liang Zeng, Jin Zhang, Haoyue Qin, Zhe Huang,Huan Yan,Gao Zhang,Yongchang Zhang
Lung cancer (Amsterdam, Netherlands) (2025): 108586-108586
Cited0Views0WOSBibtex
0
0
RET-AREAL: a Multi-Center, Real-World Data Analysis on the Efficacy of Pralsetinib in Acquired RET Fusion after Resistance to EGFR/ALK-TKIs
Xinjun Tang,Jie Hu,Renhua Guo,Yina Wang,Yu Yao,Liang Zeng,Haitao Wang, Haibo Shen,Jun Chen, Weina Huang, Lihua Liu, Ming Su,Zhuang Yu,Weidong Mao,Jinliang Wang, Haitao Tao,Guilan Dong,Chang Cai,Yupeng Xie,Tao Qu, Yan Zhang, Wei Shen, Jing Cao, Xin Cai, Wencui Kong, Xiaoxue Li, Fei Liang
CANCER LETTERS (2025)
Cited0Views0WOSBibtex
0
0
Strategies Beyond 3rd EGFR-TKI Acquired Resistance: Opportunities and Challenges
Xuexue Zhou,Liang Zeng, Zhe Huang, Zhaohui Ruan,Huan Yan, Chun Zou, Shidong Xu,Yongchang Zhang
Cancer medicineno. 9 (2025): e70921-e70921
Cited0Views0WOSBibtex
0
0
Preclinical and Translational Study Design
Liang Zeng, Xing Zhang, Hongzhi Ma
New Anti-cancer Drug Development and Evaluationpp.53-76, (2024)
Cited0Views0Bibtex
0
0
Load More
Author Statistics

#Papers: 0

#Citation: 0

H-Index: 0

G-Index: 0

Sociability: 0

Diversity: 0

Activity: 0

  • 合作者
  • 学生
  • 导师
No result temporarily, you can search similar Scholar with the same research interest
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn